메뉴 건너뛰기




Volumn 27, Issue 7, 2002, Pages 578-584

Cytokines: Interleukin and interferon therapy in dermatology

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTINEOPLASTIC AGENT; BETA INTERFERON; CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR; INTERFERON; INTERLEUKIN 10; INTERLEUKIN 11; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA;

EID: 0036456831     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2230.2002.01144.x     Document Type: Review
Times cited : (39)

References (34)
  • 1
    • 0025605056 scopus 로고
    • Evidence for an epidermal cytokine network
    • Luger TA, Schwarz T. Evidence for an epidermal cytokine network. J Invest Dermatol 1990; 95: 100S-104S.
    • (1990) J Invest Dermatol , vol.95
    • Luger, T.A.1    Schwarz, T.2
  • 3
    • 0002831954 scopus 로고    scopus 로고
    • Durable complete responses in metastatic melanoma treated with interleukin-2 in combination with interferon alpha and chemotherapy
    • Legha SS. Durable complete responses in metastatic melanoma treated with interleukin-2 in combination with interferon alpha and chemotherapy. J Clin Oncol 1996; 14:7-17.
    • (1996) J Clin Oncol , vol.14 , pp. 7-17
    • Legha, S.S.1
  • 4
    • 0034088027 scopus 로고    scopus 로고
    • High- and low-dose interferon alfa-2b in high-risk melanoma: First analysis of intergroup trial E1690/S9111/C9190
    • Kirkwood JM, Ibrahim JG, Sondak VK et al. High- and low-dose interferon alfa-2b in high-risk melanoma: First analysis of intergroup trial E1690/S9111/C9190. J Clin Oncol 2000; 18: 2444-58.
    • (2000) J Clin Oncol , vol.18 , pp. 2444-2458
    • Kirkwood, J.M.1    Ibrahim, J.G.2    Sondak, V.K.3
  • 5
    • 0035339880 scopus 로고    scopus 로고
    • High-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH/QS-21 vaccine in patients with resected stage IIB-III melanoma: Results of intergroup trial E1694/S9512/C509801
    • Kirkwood JM, Ibrahim JG, Sosman JA et al. High-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH/QS-21 vaccine in patients with resected stage IIB-III melanoma: Results of intergroup trial E1694/S9512/C509801. J Clin Oncol 2001; 19: 2370-80.
    • (2001) J Clin Oncol , vol.19 , pp. 2370-2380
    • Kirkwood, J.M.1    Ibrahim, J.G.2    Sosman, J.A.3
  • 7
    • 0032533917 scopus 로고    scopus 로고
    • Prospective randomized multicenter clinical trial on the use of interferon-2a plus acitretin versus interferon-2a plus PUVA in patients with cutaneous T-cell lymphoma stages I and II
    • Stadler R, Otte HG, Luger T et al. Prospective randomized multicenter clinical trial on the use of interferon-2a plus acitretin versus interferon-2a plus PUVA in patients with cutaneous T-cell lymphoma stages I and II. Blood 1998; 92: 3578-81.
    • (1998) Blood , vol.92 , pp. 3578-3581
    • Stadler, R.1    Otte, H.G.2    Luger, T.3
  • 8
    • 0030927592 scopus 로고    scopus 로고
    • Extracorporeal photopheresis and interferon-alpha in advanced cutaneous T-cell lymphoma
    • Dippel E, Schrag H, Goerdt S, Orfanos CE. Extracorporeal photopheresis and interferon-alpha in advanced cutaneous T-cell lymphoma. Lancet 1997; 350: 32-3.
    • (1997) Lancet , vol.350 , pp. 32-33
    • Dippel, E.1    Schrag, H.2    Goerdt, S.3    Orfanos, C.E.4
  • 9
    • 0032009981 scopus 로고    scopus 로고
    • HIV-1, HHV-8, and Kaposi's sarcoma
    • Gallo RC. HIV-1, HHV-8, and Kaposi's sarcoma. J Hum Virol 1998; 1: 185-6.
    • (1998) J Hum Virol , vol.1 , pp. 185-186
    • Gallo, R.C.1
  • 11
  • 12
    • 0025083873 scopus 로고
    • Intralesional interferon therapy for basal cell carcinoma
    • Cornell RC, Greenway HT, Tucker SB et al. Intralesional interferon therapy for basal cell carcinoma. J Am Acad Dermatol 1990; 23: 694-700.
    • (1990) J Am Acad Dermatol , vol.23 , pp. 694-700
    • Cornell, R.C.1    Greenway, H.T.2    Tucker, S.B.3
  • 14
    • 2642712490 scopus 로고    scopus 로고
    • Therapy of human papillomavirus infection and associated epithelial tumors
    • Gross G. Therapy of human papillomavirus infection and associated epithelial tumors. Intervirology 1997; 40: 368-77.
    • (1997) Intervirology , vol.40 , pp. 368-377
    • Gross, G.1
  • 15
    • 0033490481 scopus 로고    scopus 로고
    • Therapeutic perspectives in atopic dermatitis
    • Leung DYM. Therapeutic perspectives in atopic dermatitis. Allergy 1999; 58: 39-42.
    • (1999) Allergy , vol.58 , pp. 39-42
    • Leung, D.Y.M.1
  • 16
    • 0032868081 scopus 로고    scopus 로고
    • Pathogenesis of atopic dermatitis
    • Leung DYM. Pathogenesis of atopic dermatitis. J Allergy Clin Immunol 1999; 104: 99-108.
    • (1999) J Allergy Clin Immunol , vol.104 , pp. 99-108
    • Leung, D.Y.M.1
  • 17
    • 0031873870 scopus 로고    scopus 로고
    • Long-term effectiveness and safety of recombinant human interferon gamma therapy for atopic dermatitis despite unchanged serum IgE levels
    • Stevens SR, Hanifin JM, Hamilton T, Tofte SJ, Cooper KD. Long-term effectiveness and safety of recombinant human interferon gamma therapy for atopic dermatitis despite unchanged serum IgE levels. Arch Dermatol 1998; 134: 799-804.
    • (1998) Arch Dermatol , vol.134 , pp. 799-804
    • Stevens, S.R.1    Hanifin, J.M.2    Hamilton, T.3    Tofte, S.J.4    Cooper, K.D.5
  • 18
    • 0031941774 scopus 로고    scopus 로고
    • Long-term therapy with recombinant interferon-gamma (rIFN-gamma) for atopic dermatitis
    • Schneider LC, Baz Z, Zarcone C, Zurakowski D. Long-term therapy with recombinant interferon-gamma (rIFN-gamma) for atopic dermatitis. Ann Allergy Asthma Immunol 1998; 80: 263-8.
    • (1998) Ann Allergy Asthma Immunol , vol.80 , pp. 263-268
    • Schneider, L.C.1    Baz, Z.2    Zarcone, C.3    Zurakowski, D.4
  • 19
    • 0034489868 scopus 로고    scopus 로고
    • Systemic therapy of atopic dermatitis
    • Sidbury R, Hanifin JM. Systemic therapy of atopic dermatitis. Clin Exp Dermatol 2000; 25: 559-66.
    • (2000) Clin Exp Dermatol , vol.25 , pp. 559-566
    • Sidbury, R.1    Hanifin, J.M.2
  • 20
    • 0032432952 scopus 로고    scopus 로고
    • Blood eosinophils and serum IgE as predictors for prognosis of interferon-gamma therapy in atopic dermatitis
    • Noh GW, Lee KY. Blood eosinophils and serum IgE as predictors for prognosis of interferon-gamma therapy in atopic dermatitis. Allergy 1998; 53: 1202-7.
    • (1998) Allergy , vol.53 , pp. 1202-1207
    • Noh, G.W.1    Lee, K.Y.2
  • 21
    • 0028266553 scopus 로고
    • Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin 2
    • Rosenberg SA, Yang JC, Topalian SL et al. Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin 2. JAMA 1994; 271: 907-13.
    • (1994) JAMA , vol.271 , pp. 907-913
    • Rosenberg, S.A.1    Yang, J.C.2    Topalian, S.L.3
  • 22
    • 17744388962 scopus 로고    scopus 로고
    • Dacarbazine and interferon alpha with or without interleukin 2 in meta-static melanoma: A randomized phase III multicentre trial of the Dermatologic Cooperative Oncology Group (DeCOG)
    • Hauschild A, Garbe C, Stolz W et al. Dacarbazine and interferon alpha with or without interleukin 2 in meta-static melanoma: A randomized phase III multicentre trial of the Dermatologic Cooperative Oncology Group (DeCOG). Br J Cancer 2001; 84: 1036-42.
    • (2001) Br J Cancer , vol.84 , pp. 1036-1042
    • Hauschild, A.1    Garbe, C.2    Stolz, W.3
  • 23
    • 0035831628 scopus 로고    scopus 로고
    • Interleukin 12 gene therapy of cancer by peritumoral injection of transduced autologous fibroblasts: Outcome of a phase I study
    • Kang WK, Park C, Yoon HL, Kim WS, Yoon SS, Lee MH. Interleukin 12 gene therapy of cancer by peritumoral injection of transduced autologous fibroblasts: Outcome of a phase I study. Hum Gene Ther 2001; 12: 671-84.
    • (2001) Hum Gene Ther , vol.12 , pp. 671-684
    • Kang, W.K.1    Park, C.2    Yoon, H.L.3    Kim, W.S.4    Yoon, S.S.5    Lee, M.H.6
  • 25
    • 0002979775 scopus 로고    scopus 로고
    • IL-4-induced immune deviation as therapy of psoriasis
    • Thomas P. IL-4-induced immune deviation as therapy of psoriasis. Arch Derm Res 2001; 293: 39.
    • (2001) Arch Derm Res , vol.293 , pp. 39
    • Thomas, P.1
  • 26
    • 0033505875 scopus 로고    scopus 로고
    • Interleukin-10 in cutaneous disorders: Implications for its pathophysiological importance and therapeutic use
    • Asadullah K, Sabat R, Wiese A, Docke WD, Volk HD, Sterry W. Interleukin-10 in cutaneous disorders: Implications for its pathophysiological importance and therapeutic use. Arch Dermatol Res 1999; 291: 628-36.
    • (1999) Arch Dermatol Res , vol.291 , pp. 628-636
    • Asadullah, K.1    Sabat, R.2    Wiese, A.3    Docke, W.D.4    Volk, H.D.5    Sterry, W.6
  • 28
    • 0032519956 scopus 로고    scopus 로고
    • IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: A new therapeutic approach
    • Asadullah K, Sterry W, Stephanek K et al. IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: A new therapeutic approach. J Clin Invest 1998; 101: 783-94.
    • (1998) J Clin Invest , vol.101 , pp. 783-794
    • Asadullah, K.1    Sterry, W.2    Stephanek, K.3
  • 29
    • 0345251966 scopus 로고    scopus 로고
    • Interleukin 10 treatment of psoriasis: Clinical results of a phase 2 trial
    • Asadullah K, Döcke WD, Ebeling M et al. Interleukin 10 treatment of psoriasis: Clinical results of a phase 2 trial. Arch Dermatol 1999; 135: 187-92.
    • (1999) Arch Dermatol , vol.135 , pp. 187-192
    • Asadullah, K.1    Döcke, W.D.2    Ebeling, M.3
  • 31
    • 0012948856 scopus 로고    scopus 로고
    • Effects of systemic interleukin-10 therapy on psoriatic skin lesions: Histological, immunohistological and molecular biological findings
    • Asadullah K, Friedrich M, Hanneken S et al. Effects of systemic interleukin-10 therapy on psoriatic skin lesions: Histological, immunohistological and molecular biological findings. J Invest Dermatol 2001; 116: 721-7.
    • (2001) J Invest Dermatol , vol.116 , pp. 721-727
    • Asadullah, K.1    Friedrich, M.2    Hanneken, S.3
  • 32
    • 0035113406 scopus 로고    scopus 로고
    • Response of Psoriasis to Interleukin-10 is Associated with Suppression of Cutaneous Type 1 Inflammation, Downregulation of the Epidermal Interleukin-8/CXCR2 Pathway and Normalization of Keratinocyte Maturation
    • Reich K, Garbe C, Blaschke V et al. Response of Psoriasis to Interleukin-10 is Associated with Suppression of Cutaneous Type 1 Inflammation, Downregulation of the Epidermal Interleukin-8/CXCR2 Pathway and Normalization of Keratinocyte Maturation. J Invest Dermatol 2001; 116: 319-29.
    • (2001) J Invest Dermatol , vol.116 , pp. 319-329
    • Reich, K.1    Garbe, C.2    Blaschke, V.3
  • 33
    • 0033404492 scopus 로고    scopus 로고
    • Interleukin-11 therapy selectively downregulates type I cytokine proinflammatory pathways in psoriasis lesions
    • Trepicchio WL, Ozawa M, Walters IB et al. Interleukin-11 therapy selectively downregulates type I cytokine proinflammatory pathways in psoriasis lesions. J Clin Invest 1999; 104: 1527-37.
    • (1999) J Clin Invest , vol.104 , pp. 1527-1537
    • Trepicchio, W.L.1    Ozawa, M.2    Walters, I.B.3
  • 34
    • 0032695429 scopus 로고    scopus 로고
    • Isolated limb perfusion with tumor necrosis factor-alpha and melphalan with or without interferon-gamma for the treatment of in-transit melanoma metastases: A multicenter randomized phase II study
    • Lienard D, Eggermont AM, Koops HS et al. Isolated limb perfusion with tumor necrosis factor-alpha and melphalan with or without interferon-gamma for the treatment of in-transit melanoma metastases: A multicenter randomized phase II study. Melanoma Res 1999; 9: 491-502.
    • (1999) Melanoma Res , vol.9 , pp. 491-502
    • Lienard, D.1    Eggermont, A.M.2    Koops, H.S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.